Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

  1. Terpos, E.
  2. Kostopoulos, I.V.
  3. Kastritis, E.
  4. Ntanasis-Stathopoulos, I.
  5. Migkou, M.
  6. Rousakis, P.
  7. Argyriou, A.T.
  8. Kanellias, N.
  9. Fotiou, D.
  10. Eleutherakis-Papaiakovou, E.
  11. Gavriatopoulou, M.
  12. Ziogas, D.C.
  13. Papanota, A.-M.
  14. Spyropoulou-Vlachou, M.
  15. Trougakos, I.P.
  16. Tsitsilonis, O.E.
  17. Paiva, B.
  18. Dimopoulos, M.A.
Revista:
HemaSphere

ISSN: 2572-9241

Any de publicació: 2019

Volum: 3

Número: 6

Tipus: Article

DOI: 10.1097/HS9.0000000000000300 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

Font de les dades: Scopus